Mercer Moves Chief Talent Officer to M&A Role
Martine Lellis, who joined Mercer as chief talent officer in 2020, will serve as principal of M&A partner development,
Source: wealthmanagement.com
📰 Greg Mayes News
Greg Mayes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Greg Mayes. Real-time updates on events, politics, business and more.
LH Council further commits to Joint Municipal Authority talks | News, Sports, Jobs
LOCK HAVEN — Lock Haven City Council is further cementing its intent to form a Joint Municipal Authority with other entities that utilize the water system.
Rick Conklin Barbara Masorti Greg Mayes Gregory Wilson Central Clinton County Water Filtration Authority Lock Haven City Council
Source: lockhaven.com
Could psychedelic drug start-ups pave the way to better mental health? Investors seem to think so
Mind-altering substances could be on the cusp of medical acceptability, with sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing their potential
Source: irishtimes.com
Mercer Global Advisors Adds to Its M&A Teams
The new executives at Mercer Global Advisors will bolster the RIA’s inorganic growth strategies.
Source: wealthmanagement.com
City, Suburban settle payment dispute | News, Sports, Jobs
LOCK HAVEN — During a special meeting this week, Lock Haven City Council, Central Clinton County Water Filtration Authority and Suburban Water Authority settl
Greg Mayes Vincent Shay Jr Jack Peters Greg Wilson Lock Haven City Council Central Clinton County Water Filtration Authority
Source: lockhaven.com
City agrees to explore Joint Municipal Authority | News, Sports, Jobs
LOCK HAVEN — The City of Lock Haven is open to joining talks about a Joint Municipal Authority with other water entities in the area. Lock Haven City Counci
Greg Mayes Municipal Authority City Authority Water Filtration Authority Water Authority E Church St
Source: lockhaven.com
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic - Mindset Pharma (OTC:MSSTF)
Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.) 
Source: benzinga.com
Reunion Neuroscience : Annual Information Form For the Fiscal Year Ended March 31, 2023
Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...
United States Concordia College New York West Virginia National Institutes Of Health University Of Maryland
Source: marketscreener.com
Reunion Neuroscience : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 12, 2023 AND MANAGEMENT INFORMATION CIRCULAR JUNE 13, 2023 ... | June 20, 2023
District Of Columbia United States Prince Edward Island Province Of Ontario United Kingdom Fred Grossman
Source: marketscreener.com
Reunion Neuroscience : Announces US$13.1 Million Take-Private Transaction with MPM BioImpact - Form 6-K
Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact Reunion Common Shareholders to Receive Consideration of US$1.12 Per Share in Cash ... | June 1, 2023
United States Wilmer Cutler Pickering Hale Greg Mayes Irina Koffler Ansbert Gadicke Lewis Goldberg Caitlin Kasunich
Source: marketscreener.com